drugset / Trial / NCT00273884
Amonafide in Combination With Cytarabine in Secondary AML
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This protocol is designed to assess the safety and efficacy of amonafide in combination with cytarabine in subjects with previously untreated secondary AML.
Timeline
- Start
- 2005-08
- Primary completion
- —
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amonafide | Small molecule | — | — |
| Background | Cytarabine | Small molecule | — | — |